Implantable defibrillator sales will rise through 2036, driven by single chambered implantable defibrillators at 34.2% of the product type segment in 2026, supported by established clinical adoption and treatment protocol integration. The market was valued at USD 2.90 billion in 2025 and is expected to be worth USD 3.72 billion by 2036.